Stilley William B. III 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Common Stock
2022-12-30−166,667→ 1,020,979 total
Footnotes (1)
- [F1]Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.